Additionally, TCF19 levels positively correlated with BRD4 protein levels and sensitivity to BETi in NRAS‐mutant melanoma cells (r = −0.740, P = 0.023; Figs 2A and B, and 5A and B). Here, TCF19 is linked to melanoma.